These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8106653)

  • 21. Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.
    Nemeroff CB
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):10S-17S. PubMed ID: 8106649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential benefits of slow titration of paroxetine treatment in an elderly population: eight-week results from a naturalistic setting.
    Gibiino S; Mori E; De Ronchi D; Serretti A
    J Clin Psychopharmacol; 2013 Aug; 33(4):565-9. PubMed ID: 23764690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxetine: an update of its use in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline.
    Hutchinson DR; Tong S; Moon CA; Vince M; Clarke A
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():43-51. PubMed ID: 1431010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
    Mertens C; Pintens H
    Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.
    Le Noury J; Nardo JM; Healy D; Jureidini J; Raven M; Tufanaru C; Abi-Jaoude E
    BMJ; 2015 Sep; 351():h4320. PubMed ID: 26376805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
    Geretsegger C; Böhmer F; Ludwig M
    Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of paroxetine and placebo in depressed outpatients.
    Dunbar GC; Claghorn JL; Kiev A; Rickels K; Smith WT
    Acta Psychiatr Scand; 1993 May; 87(5):302-5. PubMed ID: 8517168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder.
    Versiani M; Mehilane L; Gaszner P; Arnaud-Castiglioni R
    J Clin Psychiatry; 1999 Jun; 60(6):400-6. PubMed ID: 10401920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
    Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine.
    Nardi AE; Freire RC; Mochcovitch MD; Amrein R; Levitan MN; King AL; Valença AM; Veras AB; Paes F; Sardinha A; Nascimento I; de-Melo-Neto VL; Dias GP; E Silva AC; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    J Clin Psychopharmacol; 2012 Feb; 32(1):120-6. PubMed ID: 22198456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study].
    Chauvet-Gélinier JC
    Encephale; 2010 Oct; 36(5):425-32. PubMed ID: 21035633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of escitalopram and paroxetine in the treatment of major depressive disorder.
    Lin HL; Hsu YT; Liu CY; Chen CH; Hsiao MC; Liu YL; Shen WW; Hsiao CF; Liu SI; Chang LH; Tang HS; Lai HL; Lin PS; Lin KM; Tsou HH
    Int Clin Psychopharmacol; 2013 Nov; 28(6):339-45. PubMed ID: 23881184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Rickels K; Athanasiou M; Robinson DS; Gibertini M; Whalen H; Reed CR
    J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.
    Baldwin DS; Hawley CJ; Mellors K;
    J Psychopharmacol; 2001 Sep; 15(3):161-5. PubMed ID: 11565622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.